Patent details

EP1804777 Title: PHARMACEUTICAL COMPOSITION COMPRISING DICLOFENAC

Basic Information

Publication number:
EP1804777
PCT Application Number:
US2005038090
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058163353
PCT Publication Number:
WO2006047365
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION COMPRISING DICLOFENAC
French Title of Invention:
COMPOSITION PHARMACEUTIQUE COMPRENANT DU DICLOFÉNAC
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DICLOFENAC
SPC Number:

Dates

Filing date:
20/10/2005
Grant date:
09/05/2018
EP Publication Date:
11/07/2007
PCT Publication Date:
04/05/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/05/2018
EP B1 Publication Date:
09/05/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/10/2018
Expiration date:
20/10/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/05/2018
 
 

Name:
Novartis Consumer Health S.A.
Address:
Route de l'Etraz 2, 1197 Prangins, Switzerland (CH)

Inventor

1

Name:
SPENCER, Gavin, Murray
Address:
France (FR)

2

Name:
MEYER, Stephan
Address:
Switzerland (CH)

3

Name:
RAULT, Isabelle
Address:
France (FR)

4

Name:
SLOMINSKI, Greg
Address:
United States (US)

5

Name:
SCHOBEL, Alexander, Mark
Address:
United States (US)

Priority

Priority Number:
620706 P
Priority Date:
21/10/2004
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/70; A61K 31/196;

Publication

European Patent Bulletin

Issue number:
201819
Publication date:
09/05/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1